Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127174682 | 12717468 | 2 | F | 201601 | 20160904 | 20160906 | 20160916 | EXP | JP-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-122221 | RANBAXY | 50.00 | YR | F | Y | 0.00000 | 20160916 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127174682 | 12717468 | 1 | PS | PAROXETINE. | PAROXETINE | 1 | Unknown | 40 MG, DAILY | U | 78194 | 40 | MG | |||||||
| 127174682 | 12717468 | 2 | SS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 100 MG, DAILY | U | 0 | 100 | MG | |||||||
| 127174682 | 12717468 | 3 | SS | Clomipramine | CLOMIPRAMINE | 1 | Unknown | 150 MG, DAILY | U | 0 | 150 | MG | |||||||
| 127174682 | 12717468 | 4 | SS | LUVOX | FLUVOXAMINE MALEATE | 1 | Unknown | 100 MG, DAILY | U | 0 | 100 | MG | |||||||
| 127174682 | 12717468 | 5 | I | LUVOX | FLUVOXAMINE MALEATE | 1 | Unknown | 25 MG, DAILY | U | U | 0 | 25 | MG | ||||||
| 127174682 | 12717468 | 6 | I | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Unknown | DOSE INCREASED BY 10 MG/DAY EVERY 4 WEEKS | 0 | 30 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127174682 | 12717468 | 1 | Obsessive-compulsive disorder |
| 127174682 | 12717468 | 2 | Obsessive-compulsive disorder |
| 127174682 | 12717468 | 3 | Obsessive-compulsive disorder |
| 127174682 | 12717468 | 4 | Obsessive-compulsive disorder |
| 127174682 | 12717468 | 5 | Obsessive-compulsive disorder |
| 127174682 | 12717468 | 6 | Obsessive-compulsive disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127174682 | 12717468 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127174682 | 12717468 | Inhibitory drug interaction | |
| 127174682 | 12717468 | Off label use | |
| 127174682 | 12717468 | Therapeutic product ineffective | |
| 127174682 | 12717468 | Therapeutic response unexpected | |
| 127174682 | 12717468 | Urinary incontinence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |